322 related articles for article (PubMed ID: 25687838)
1. Potentiation of neurite outgrowth by brexpiprazole, a novel serotonin-dopamine activity modulator: a role for serotonin 5-HT1A and 5-HT2A receptors.
Ishima T; Futamura T; Ohgi Y; Yoshimi N; Kikuchi T; Hashimoto K
Eur Neuropsychopharmacol; 2015 Apr; 25(4):505-11. PubMed ID: 25687838
[TBL] [Abstract][Full Text] [Related]
2. Neurite outgrowth mediated by the heat shock protein Hsp90α: a novel target for the antipsychotic drug aripiprazole.
Ishima T; Iyo M; Hashimoto K
Transl Psychiatry; 2012 Oct; 2(10):e170. PubMed ID: 23047241
[TBL] [Abstract][Full Text] [Related]
3. Brexpiprazole I: in vitro and in vivo characterization of a novel serotonin-dopamine activity modulator.
Maeda K; Sugino H; Akazawa H; Amada N; Shimada J; Futamura T; Yamashita H; Ito N; McQuade RD; Mørk A; Pehrson AL; Hentzer M; Nielsen V; Bundgaard C; Arnt J; Stensbøl TB; Kikuchi T
J Pharmacol Exp Ther; 2014 Sep; 350(3):589-604. PubMed ID: 24947465
[TBL] [Abstract][Full Text] [Related]
4. Potentiation of nerve growth factor-induced neurite outgrowth in PC12 cells by donepezil: role of sigma-1 receptors and IP3 receptors.
Ishima T; Nishimura T; Iyo M; Hashimoto K
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Oct; 32(7):1656-9. PubMed ID: 18647636
[TBL] [Abstract][Full Text] [Related]
5. Involvement of presynaptic 5-HT
Mombereau C; Arnt J; Mørk A
Pharmacol Biochem Behav; 2017 Feb; 153():141-146. PubMed ID: 28057524
[TBL] [Abstract][Full Text] [Related]
6. Potentiation of nerve growth factor-induced neurite outgrowth in PC12 cells by ifenprodil: the role of sigma-1 and IP3 receptors.
Ishima T; Hashimoto K
PLoS One; 2012; 7(5):e37989. PubMed ID: 22655093
[TBL] [Abstract][Full Text] [Related]
7. Potentiation of nerve growth factor-induced neurite outgrowth by the ROCK inhibitor Y-27632: a possible role of IP₃ receptors.
Minase T; Ishima T; Itoh K; Hashimoto K
Eur J Pharmacol; 2010 Dec; 648(1-3):67-73. PubMed ID: 20854802
[TBL] [Abstract][Full Text] [Related]
8. A positron emission tomography occupancy study of brexpiprazole at dopamine D
Girgis RR; Forbes A; Abi-Dargham A; Slifstein M
Neuropsychopharmacology; 2020 Apr; 45(5):786-792. PubMed ID: 31847007
[TBL] [Abstract][Full Text] [Related]
9. Potentiation of nerve growth factor-induced neurite outgrowth by fluvoxamine: role of sigma-1 receptors, IP3 receptors and cellular signaling pathways.
Nishimura T; Ishima T; Iyo M; Hashimoto K
PLoS One; 2008 Jul; 3(7):e2558. PubMed ID: 18596927
[TBL] [Abstract][Full Text] [Related]
10. Brexpiprazole II: antipsychotic-like and procognitive effects of a novel serotonin-dopamine activity modulator.
Maeda K; Lerdrup L; Sugino H; Akazawa H; Amada N; McQuade RD; Stensbøl TB; Bundgaard C; Arnt J; Kikuchi T
J Pharmacol Exp Ther; 2014 Sep; 350(3):605-14. PubMed ID: 24947464
[TBL] [Abstract][Full Text] [Related]
11. [Aripiprazol potentiates NGF-induced neurite outgrowth].
Ishima T; Iyo M; Hashimoto K
Nihon Shinkei Seishin Yakurigaku Zasshi; 2013 Apr; 33(2):59-60. PubMed ID: 25314739
[No Abstract] [Full Text] [Related]
12. Effects of brexpiprazole, a novel serotonin-dopamine activity modulator, on phencyclidine-induced cognitive deficits in mice: a role for serotonin 5-HT1A receptors.
Yoshimi N; Fujita Y; Ohgi Y; Futamura T; Kikuchi T; Hashimoto K
Pharmacol Biochem Behav; 2014 Sep; 124():245-9. PubMed ID: 24955861
[TBL] [Abstract][Full Text] [Related]
13. Interaction of the novel antipsychotic aripiprazole with 5-HT1A and 5-HT 2A receptors: functional receptor-binding and in vivo electrophysiological studies.
Stark AD; Jordan S; Allers KA; Bertekap RL; Chen R; Mistry Kannan T; Molski TF; Yocca FD; Sharp T; Kikuchi T; Burris KD
Psychopharmacology (Berl); 2007 Feb; 190(3):373-82. PubMed ID: 17242925
[TBL] [Abstract][Full Text] [Related]
14. Brexpiprazole has a low risk of dopamine D
Amada N; Akazawa H; Ohgi Y; Maeda K; Sugino H; Kurahashi N; Kikuchi T; Futamura T
Neuropsychopharmacol Rep; 2019 Dec; 39(4):279-288. PubMed ID: 31487433
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of action of brexpiprazole: comparison with aripiprazole.
Stahl SM
CNS Spectr; 2016 Feb; 21(1):1-6. PubMed ID: 26899451
[TBL] [Abstract][Full Text] [Related]
16. Potentiation of NGF-induced neurite outgrowth in PC12 cells by papaverine: role played by PLC-γ, IP3 receptors.
Itoh K; Ishima T; Kehler J; Hashimoto K
Brain Res; 2011 Mar; 1377():32-40. PubMed ID: 21211516
[TBL] [Abstract][Full Text] [Related]
17. Acute effects of brexpiprazole on serotonin, dopamine, and norepinephrine systems: an in vivo electrophysiologic characterization.
Oosterhof CA; El Mansari M; Blier P
J Pharmacol Exp Ther; 2014 Dec; 351(3):585-95. PubMed ID: 25225185
[TBL] [Abstract][Full Text] [Related]
18. Aripiprazole inhibits marble-burying behavior via 5-hydroxytryptamine (5-HT)1A receptor-independent mechanisms.
Egashira N; Okuno R; Matsushita M; Abe M; Mishima K; Iwasaki K; Nishimura R; Oishi R; Fujiwara M
Eur J Pharmacol; 2008 Sep; 592(1-3):103-8. PubMed ID: 18644366
[TBL] [Abstract][Full Text] [Related]
19. Serotonin 5-HT
Gener T; Tauste Campo A; Alemany-González M; Nebot P; Delgado-Sallent C; Chanovas J; Puig MV
Neuropharmacology; 2019 Nov; 158():107743. PubMed ID: 31430459
[TBL] [Abstract][Full Text] [Related]
20. Serotonin (5-HT) regulates neurite outgrowth through 5-HT1A and 5-HT7 receptors in cultured hippocampal neurons.
Rojas PS; Neira D; Muñoz M; Lavandero S; Fiedler JL
J Neurosci Res; 2014 Aug; 92(8):1000-9. PubMed ID: 24752854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
